TriMas Lifted Profit as Sales Growth Stalled
The company raised the low end of its 2026 adjusted earnings outlook to $1.60 a share.
TriMas Corporation (TRS), the engineered-products manufacturer, more than doubled second-quarter adjusted earnings as cost reductions and a lower share count helped offset slowing sales growth. Adjusted diluted earnings from continuing operations rose 160% to $0.52 a share from $0.20 a year earlier.
The quarter marked a sharp change in the growth mix. Continuing-operations sales rose 1.6% to $174.6 million after increasing 10.4% in the first quarter, while organic growth slowed to zero from 7.3%. The entire second-quarter increase came from a 1.6% favorable currency effect.
Profit continued to grow faster than revenue. Adjusted operating profit increased 29.1% to $14.9 million, and adjusted operating margin widened about 180 basis points to 8.5%. Gross margin moved in the other direction, falling to about 20.2% from 22.1% as cost of sales rose faster than revenue.
Packaging sales were essentially unchanged at $142.9 million, following 9.1% growth in the first quarter. Lower beauty and personal-care and food-and-beverage sales offset growth in industrial and life-sciences markets, weakening a mix that had supported the prior quarter’s expansion.
Specialty Products became the main source of organic growth, with sales rising 10.2% to $31.7 million. Its operating profit and margin declined, however, as raw-material cost recovery lagged and machine downtime and labor ramp-up created temporary manufacturing inefficiencies.
TriMas now expects 2026 adjusted earnings of $1.60 to $1.70 a share, compared with its previous range of $1.50 to $1.70. It continues to project sales growth of 3% to 6% and more than 300 basis points of adjusted operating-margin improvement. Expected annualized cost savings rose to $16 million, including about $10.5 million anticipated this year, and the company completed the consolidation of its Atkins, Arkansas, packaging facility.
The March sale of the Aerospace business produced about $1.2 billion in net after-tax proceeds and shifted the operation to discontinued-operations treatment. TriMas ended June with $845.6 million of net cash, compared with $439.2 million of net debt at year-end, while repurchases reduced outstanding shares 4.7% over that span. Free cash flow remained negative at $12.9 million, leaving cash deployment and conversion as the next tests for its reshaped portfolio.